Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells. [electronic resource]
Producer: 20170828Description: 2465-74 p. digitalISSN:- 1476-5594
- Apoptosis -- drug effects
- Breast Neoplasms -- pathology
- Camptothecin -- analogs & derivatives
- Cell Line, Tumor
- Gene Knockout Techniques
- Genomics
- Herpesvirus 1, Human -- physiology
- Humans
- Irinotecan
- Lentivirus -- genetics
- Oncolytic Virotherapy
- Phosphorylation -- drug effects
- RNA, Small Interfering -- genetics
- Serine-Arginine Splicing Factors -- deficiency
- Virus Replication -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.